Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
Recruiting
N/A
Interventional Study
Survivor of Childhood Cancer
Insomnia
Acute Lymphoblastic Leukemia (ALL)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 50
- Sex
- Any
- Study type
- Interventional
- Purpose
- Device Feasibility
- Participants needed
- 40 (estimated)
- Sponsor
- St. Jude Children's Research Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This pilot study will assess the usefulness and potential effectiveness of using transcutaneous auricular vagus nerve stimulation (tVNS) for treating insomnia in adult survivors of childhood acute lymphoblastic leukemia (ALL). Participants will be randomized to receive either active (verum) or inactive (sham) nightly stimulation using a non-invasive earbud device over two time periods: 2 weeks and…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Survivor of Acute Lymphoblastic Leukemia (ALL)
* Enrolled on SJLIFE
* Participant was less than 21 years of age at time of diagnosis.
* Age 20-50 years at the time of enrollment
* Insomnia Severity Index \>=8 (Proxy \>=8) confirmed prior to enrollment
* Access to home Wi-Fi an…
Contacts